Novel Nox inhibitor VAS2870 attenuates PDGF-dependent smooth muscle cell chemotaxis, but not proliferation☆
Abstract
OBJECTIVE: Reactive oxygen species (ROS) produced by NAD(P)H oxidases (Nox) play a significant role in the pathophysiology of cardiovascular diseases. Expression and activity of NAD(P)H oxidases are regulated by growth factors such as angiotensin II and platelet-derived growth factor (PDGF). We characterized the effects of the novel Nox inhibitor VAS2870 on PDGF-dependent ROS liberation and cellular events in vascular smooth muscle cells (VSMC). METHODS AND RESULTS: PDGF-BB increased NAD(P)H oxidase activity (lucigenin-enhanced chemiluminescence) and intracellular ROS levels (detected by confocal laserscanning microscopy using 2,7-DCF) to 229+/-9% and 362+/-54% at 1 and 2 h, respectively. Preincubation with VAS2870 (10 and 20 microM) completely abolished PDGF-mediated NAD(P)H oxidase activation and ROS production. Since ROS are involved in various growth factor-induced cellular functions, the influence of VAS2870 on PDGF-induced DNA synthesis and chemotaxis was determined. PDGF promoted a 4.2+/-0.2-fold increase of VSMC migration (modified Boyden chamber, p<0.01) and increased DNA synthesis by maximally 3.2+/-0.4-fold (BrdU incorporation, p<0.01) in a concentration-dependent manner. Preincubation with VAS2870 (0.1-20 microM) did not affect PDGF-induced cell cycle progression. However, it abolished PDGF-dependent chemotaxis of VSMC in a concentration-dependent manner (100% inhibition at 10 microM). These findings were related to PDGF-dependent signaling events. Western blot analyses using phospho-specific antibodies revealed that the downstream signaling molecules Akt, Erk, and Src were activated by PDGF. However, VAS2870 blocked PDGF-dependent activation of Src, but not of Akt and Erk, in a concentration-dependent manner. CONCLUSIONS: VAS2870 effectively suppresses growth factor-mediated ROS liberation in VSMC. Furthermore, it completely inhibits PDGF-dependent VSMC migration, whereas it does not affect DNA synthesis. These divergent effects reflect the critical role of Src activity, which-in contrast to Akt and Erk-appears to be redox-sensitive and is absolutely required for PDGF-induced chemotaxis, but not cell cycle progression.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The scheme of heme protein-mediated nitrite reduction applies to virtually all heme proteins studied to date, including Hb, Mb, Ngb, Cygb, CBS, globin X, plant and cyanobacterial Hb, flavohemoglobin, heme-albumin, cytochrome c, protoglobin, and microperoxidase-11.
“This scheme has been found to apply to virtually all the heme protein–mediated nitrite reduction reactions studied to date, including Hb (248, 447), Mb (247, 862), neuroglobin (Ngb) (932, 945), Cygb (182, 571, 780), cystathionine β-synthase (CBS) (149, 350), globin X (184), plant and cyanobacterial Hb (phytohemoglobins) (905, 946), flavohemoglobin (340), heme-albumin (43), cytochrome c (41), prot”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [932]
Deoxygenated Ngb can reduce nitrite to NO.
“It was recently demonstrated that, as observed with other globins, deoxygenated Ngb can also reduce nitrite to NO (932, 945).”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [932]
VAS2870 is definitely not Nox2-specific.
“However, although initial experiments suggested VAS2870 to be Nox2-specific, it is definitely not [341,393,403,404].”
From Functions of ROS in Macrophages and Antimicrobial Immunity (2021) · cites this paper as [404]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress
Cai, H., & Harrison, D. G. (2000) · Circulation Research · doi:10.1161/01.res.87.10.840 · Cited by 3,839 · see citing works
Sundaresan, M., Yu, Z.-X., Ferrans, V. J., Irani, K., & Finkel, T. (1995) · Science · doi:10.1126/science.270.5234.296 · Cited by 2,520 · see citing works
The smooth muscle cell in culture
Chamley-Campbell, J. H., CAMPBELL, G. R., & Ross, R. (1979) · Physiological Reviews · doi:10.1152/physrev.1979.59.1.1 · Cited by 1,560 · see citing works
Cell transformation by the superoxide-generating oxidase Mox1
Suh, Y.-A., Arnold, R. S., Lassegue, B., Shi, J., Xu, X., Sorescu, D., Chung, A. B., Griendling, K. K., & Lambeth, J. D. (1999) · Nature · doi:10.1038/43459 · Cited by 1,480 · see citing works
Vascular NAD(P)H oxidases: specific features, expression, and regulation
Lassegue, B. P., & Clempus, R. E. (2003) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00758.2002 · Cited by 1,016 · see citing works
Superoxide Production and Expression of Nox Family Proteins in Human Atherosclerosis
Sorescu, D., Weiss, D., Lassègue, B., Clempus, R. E., Szöcs, K., Sorescu, G. P., Valppu, L., Quinn, M. T., Lambeth, J. D., Vega, J. D., et al. (2002) · Circulation · doi:10.1161/01.cir.0000012917.74432.66 · Cited by 847 · see citing works
Identification of Renox, an NAD(P)H oxidase in kidney
Geiszt, M., Kopp, J. B., Várnai, P., & Leto, T. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.130135897 · Cited by 840 · see citing works
Lassègue, B., Sorescu, D., Szöcs, K., Yin, Q., Akers, M., Zhang, Y., Grant, S. L., Lambeth, J. D., & Griendling, K. K. (2001) · Circulation Research · doi:10.1161/hh0901.090299 · Cited by 839 · see citing works
Homologs of gp91 phox : cloning and tissue expression of Nox3, Nox4, and Nox5
Cheng, G., Cao, Z., Xu, X., Meir, E. G. V., & Lambeth, J. D. (2001) · Gene · doi:10.1016/s0378-1119(01)00449-8 · Cited by 820 · see citing works
The superoxide-generating NADPH oxidase: structural aspects and activation mechanism
Vignais, P. V. (2002) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-002-8520-9 · Cited by 773 · see citing works
Angiotensin II Stimulation of NAD(P)H Oxidase Activity
Seshiah, P., Weber, D. S., Ročić, P., Valppu, L., Taniyama, Y., & Griendling, K. K. (2002) · Circulation Research · doi:10.1161/01.res.0000033523.08033.16 · Cited by 709 · see citing works
The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases
Cai, H., Griendling, K. K., & Harrison, D. G. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(03)00233-5 · Cited by 687 · see citing works
Stolk, J. N., Hiltermann, T. J. N., Dijkman, J. H., & Verhoeven, A. J. (1994) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.11.1.8018341 · Cited by 650 · see citing works
Rey, F. E., Cifuentes-Pagano, E., Kiarash, A., Quinn, M. T., & Pagano, P. J. (2001) · Circulation Research · doi:10.1161/hh1701.096037 · Cited by 606 · see citing works
Görlach, A., Brandes, R. P., Nguyen, K., Amidi, M., Dehghani, F., & Busse, R. (2000) · Circulation Research · doi:10.1161/01.res.87.1.26 · Cited by 598 · cited 1× · see citing works
“In vascular smooth muscle cells (VSMC), expression of Nox1, Nox4, and Nox5 has been detected [9,17,20,35].”
BackgroundTouyz, R. M., Chen, X., Tabet, F., Yao, G., He, G., Quinn, M. T., Pagano, P. J., & Schiffrin, E. L. (2002) · Circulation Research · doi:10.1161/01.res.0000020404.01971.2f · Cited by 590 · see citing works
NADH/NADPH Oxidase and Enhanced Superoxide Production in the Mineralocorticoid Hypertensive Rat
Beswick, R. A., Dorrance, A. M., Leite, R., & Webb, R. C. (2001) · Hypertension · doi:10.1161/hy1101.093423 · Cited by 346 · see citing works
Activation of NADPH Oxidase in Alzheimer’s Disease Brains
Shimohama, S., Tanino, H., Kawakami, N., Okamura, N., Kodama, H., Yamaguchi, T., Hayakawa, T., Nunomura, A., Chiba, S., Perry, G., et al. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2897 · Cited by 292 · see citing works
Brown, M. R., Miller, F. J., Li, W.-G., Ellingson, A. N., Mozena, J. D., Chatterjee, P., Engelhardt, J. F., Zwacka, R. M., Oberley, L. W., Fang, X., et al. (1999) · Circulation Research · doi:10.1161/01.res.85.6.524 · Cited by 219 · see citing works
Lin, M., Yen, M., Lin, C., & Kuo, M. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.5.1029 · Cited by 208 · see citing works
Majander, A. S., Finel, M., & Wikström, M. K. F. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31926-9 · Cited by 202 · see citing works
Geiszt, M., Lekstrom, K. J., Brenner, S., Hewitt, S. M., Dana, R., Malech, H. L., & Leto, T. L. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.1.299 · Cited by 201 · see citing works
Diatchuk, V., Lotan, O., Koshkin, V., Wikstroem, P., & Pick, E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.20.13292 · Cited by 196 · see citing works
An NAD(P)H oxidase regulates growth and transcription in melanoma cells
Brar, S. S., Kennedy, T. P., Sturrock, A., Huecksteadt, T. P., Quinn, M. T., Whorton, A. R., & Hoidal, J. R. (2002) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00496.2001 · Cited by 178 · see citing works
Weber, D. S., Taniyama, Y., Ročić, P., Seshiah, P., Dechert, M. A., Gerthoffer, W. T., & Griendling, K. K. (2004) · Circulation Research · doi:10.1161/01.res.0000126848.54740.4a · Cited by 162 · see citing works
A central role for the endothelial NADPH oxidase in atherosclerosis
Meyer, J. W., & Schmitt, M. E. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01397-1 · Cited by 148 · see citing works
Jacobson, G. M., Dourron, H. M., Liu, J., Carretero, O. A., Reddy, D. J., Andrzejewski, T., & Pagano, P. J. (2003) · Circulation Research · doi:10.1161/01.res.0000063423.94645.8a · Cited by 144 · see citing works
NADPH oxidase promotes NF-kappaB activation and proliferation in human airway smooth muscle.
Brar, S., Kennedy, T., Sturrock, A., Huecksteadt, T., Quinn, M., Murphy, T. M., Chitano, P., & Hoidal, J. (2002) · American Journal of Physiology - Lung cellular and Molecular Physiology · doi:10.1152/ajplung.00206.2001 · Cited by 118 · see citing works
Esposito, F., Chirico, G., Gesualdi, N. M., Posadas, I., Ammendola, R., Russo, T., Cirino, G., & Cimino, F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211841200 · Cited by 117 · see citing works
Waltenberger, J. L., Uecker, A., Krøll, J., Frank, H., Mayr, U., Bjorge, J. D., Fujita, D. J., Gazit, A., Hombach, V., Levitzki, A., et al. (1999) · Circulation Research · doi:10.1161/01.res.85.1.12 · Cited by 111 · see citing works
Rosenkranz, S., Knirel, D., Dietrich, H., Flesch, M., Erdmann, E., & Böhm, M. (2002) · The FASEB Journal · doi:10.1096/fj.02-0207fje · Cited by 106 · see citing works
Self-citationKalinina, N., Agrotis, A., Tararak, E. M., Antropova, Y., Kanellakis, P., Ilyinskaya, O. P., Quinn, M. T., Smirnov, V. N., & Bobik, A. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000040222.02255.0f · Cited by 103 · see citing works
Engels, F., Renirie, B. F., Hart, B. A. ‘., Labadie, R. P., & Nijkamp, F. P. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)80680-f · Cited by 102 · see citing works
Hydrogen Peroxide Formation by Cells Treated with a Tumor Promoter
Frenkel, K., & Gleichauf, C. (1991) · Free Radical Research Communications · doi:10.3109/10715769109145860 · Cited by 89 · see citing works
Rosenkranz, S., DeMali, K. A., Gelderloos, J. A., Bazenet, C. E., & Kazlauskas, A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.40.28335 · Cited by 86 · see citing works
Self-citationApocynin increases glutathione synthesis and activates AP‐1 in alveolar epithelial cells
Lapperre, T. S., Jimenez, L. A., Antonicelli, F. D., Drost, E., Hiemstra, P. S., Stolk, J. N., MacNee, W., & Rahman, I. (1999) · FEBS Letters · doi:10.1016/s0014-5793(98)01723-2 · Cited by 79 · see citing works
Leusen, J. H. W., Fluiter, K., Hilarius, P. M., Roos, D., Verhoeven, A. J., & Bolscher, B. G. J. M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.19.11216 · Cited by 76 · see citing works
Wang, Z. (2003) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2003.09.014 · Cited by 76 · see citing works
Locher, R., Brandes, R. P., Vetter, W., & Barton, M. (2002) · Hypertension · doi:10.1161/hy0202.103473 · Cited by 69 · see citing works
Greene, E. L., Lü, G., Zhang, D., & Egan, B. M. (2001) · Hypertension · doi:10.1161/01.hyp.37.2.308 · Cited by 65 · see citing works
Park, J., Ha, H., Seo, J., Kim, M. S., Kim, H. J., Huh, K. H., Park, K., & Kim, Y. S. (2004) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2004.00610.x · Cited by 58 · see citing works
Role of reactive oxygen species in bradykinin-induced proliferation of vascular smooth muscle cells
Velarde, V., CERDA, P. M. D. L., DUARTE, C., Arancibia-Galilea, F., Abbott, E., Alejandro González, A., MORENO, F., & Jaffa, A. A. (2004) · Biological Research · doi:10.4067/s0716-97602004000300007 · Cited by 43 · see citing works
Nitric oxide synthase and NAD(P)H oxidase modulate coronary endothelial cell growth
Bayraktutan, U. (2003) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2003.11.005 · Cited by 23 · see citing works
Cyclin E and cyclin A are likely targets of Src for PDGF‐induced DNA synthesis in fibroblasts
Furstoss, O., Manes, G., & Roche, S. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03120-4 · Cited by 13 · see citing works
Flagged first, then by citations
2 of the 46 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Sundaresan M, Yu ZX, Ferrans VJ, Irani K, Finkel T. Requirement for generation of H2O2 for platelet-derived growth factor signal trans- duction. Science 1995;270:296 -9.
Cited by
Sorted by citations
A tissue-scale gradient of hydrogen peroxide mediates rapid wound detection in zebrafish
Niethammer, P., Grabher, C., Look, A. T., & Mitchison, T. J. (2009) · Nature · doi:10.1038/nature08119 · Cited by 1,541 · see citing works
NADPH oxidases: An overview from structure to innate immunity-associated pathologies
Panday, A., Sahoo, M. K., Osorio, D., & Batra, S. (2015) · Cellular & Molecular Immunology · doi:10.1038/cmi.2014.89 · Cited by 944 · see citing works
Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets
Drummond, G. R., Selemidis, S., Griendling, K. K., & Sobey, C. G. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3403 · Cited by 899 · see citing works
Oxidative stress and pathophysiology of ischemic stroke: novel therapeutic opportunities.
Rodrigo, R., Fernández-Gajardo, R., Gutiérrez, R., Matamala, J. M., Carrasco, R., Miranda-Merchak, A., & Feuerhake, W. (2013) · CNS and Neurological Disorders - Drug Targets · doi:10.2174/1871527311312050015 · Cited by 621 · see citing works
Functions of ROS in Macrophages and Antimicrobial Immunity
Herb, M., & Schramm, M. (2021) · Antioxidants · doi:10.3390/antiox10020313 · Cited by 633 · see citing works
Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation
Tejero, J., Shiva, S., & Gladwin, M. T. (2019) · Physiological Reviews · doi:10.1152/physrev.00036.2017 · Cited by 541 · see citing works
NADPH oxidases and oxidase crosstalk in cardiovascular diseases: novel therapeutic targets
Zhang, Y., Murugesan, P., Huang, K., & Cai, H. “. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0260-8 · Cited by 546 · see citing works
Evolution of nadph oxidase inhibitors: Selectivity and mechanisms for target engagement
Altenhöfer, S., Radermacher, K. A., Kleikers, P. W. M., Wingler, K., & Schmidt, H. H. H. W. (2015) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5814 · Cited by 521 · see citing works
Self-citationNADPH Oxidases in Vascular Pathology
Konior, A., Schramm‐Luc, A., Cześnikiewicz‐Guzik, M., & Guzik, T. J. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5607 · Cited by 451 · see citing works
Kleinschnitz, C., Grund, H., Wingler, K., Armitage, M. E., Jones, E., Mittal, M., Barit, D., Schwarz, T., Geis, C., Kraft, P., et al. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000479 · Cited by 447 · see citing works
Self-citationNADPH oxidase in brain injury and neurodegenerative disorders
Ma, M. W., Wang, J., Zhang, Q., Wang, R., Dhandapani, K. M., Vadlamudi, R. K., & Brann, D. W. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0150-7 · Cited by 432 · see citing works
The NOX toolbox: validating the role of NADPH oxidases in physiology and disease
Altenhöfer, S., Kleikers, P. W. M., Radermacher, K. A., Scheurer, P., Rob Hermans, J. J., Schiffers, P., Ho, H., Wingler, K., & Schmidt, H. H. H. W. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1010-9 · Cited by 371 · see citing works
Self-citationBasic Mechanisms of Oxidative Stress and Reactive Oxygen Species in Cardiovascular Injury
Papaharalambus, C. A., & Griendling, K. K. (2007) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2006.11.005 · Cited by 351 · see citing works
Hervera, A., Virgiliis, F. D., Palmisano, I., Zhou, L., Tantardini, E., Kong, G., Hutson, T. H., Danzi, M. C., Perry, R. B., Santos, C. X. C., et al. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0039-x · Cited by 333 · see citing works
Role of reactive oxygen and nitrogen species in the vascular responses to inflammation
Kvietys, P. R., & Granger, D. N. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.11.002 · Cited by 313 · see citing works
Vascular Oxidative Stress: Impact and Therapeutic Approaches
Sena, C. M., Leandro, A., Azul, L., Seiça, R. M. F., & Perry, G. L. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01668 · Cited by 260 · see citing works
Small-Molecule NOX Inhibitors: ROS-Generating NADPH Oxidases as Therapeutic Targets
Jaquet, V., Scapozza, L., Clark, R. A., Krause, K. H., & Lambeth, J. D. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2585 · Cited by 243 · see citing works
Diaz, B., Shani, G., Pass, I., Anderson, D., Quintavalle, M., & Courtneidge, S. A. (2009) · Science Signaling · doi:10.1126/scisignal.2000368 · Cited by 242 · see citing works
Redox Signaling, Vascular Function, and Hypertension
Lee, M. Y., & Griendling, K. K. (2008) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1986 · Cited by 241 · see citing works
Selemidis, S., Sobey, C. G., Wingler, K., Schmidt, H. H. H. W., & Drummond, G. R. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.08.005 · Cited by 241 · see citing works
Self-citationComparative pharmacology of chemically distinct nadph oxidase inhibitors
Wind, S., Beuerlein, K., Eucker, T., Müller, H., Scheurer, P., Armitage, M., Ho, H., Schmidt, H., & Wingler, K. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00920.x · Cited by 241 · see citing works
Self-citationMechanisms and consequences of endothelial nitric oxide synthase dysfunction in hypertension
Li, Q., Youn, J.-Y., & Cai, H. “. (2015) · Journal of Hypertension · doi:10.1097/hjh.0000000000000587 · Cited by 237 · see citing works
CaMKII in the Cardiovascular System: Sensing Redox States
Erickson, J. R., He, B. J., Grumbach, I. M., & Anderson, M. E. (2011) · Physiological Reviews · doi:10.1152/physrev.00018.2010 · Cited by 238 · see citing works
Lee, M. Y., Martín, A. S., Mehta, P. K., Dikalova, A., Garrido, A. M., Datla, S. R., Lyons, E., Krause, K., Bánfi, B., Lambeth, J. D., et al. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.181925 · Cited by 234 · see citing works
Targeting NADPH oxidases in vascular pharmacology
Schramm‐Luc, A., Matusik, P. T., Osmenda, G., & Guzik, T. J. (2012) · Vascular Pharmacology · doi:10.1016/j.vph.2012.02.012 · Cited by 229 · see citing works
Hydrogen Peroxide as a Signaling Molecule
Veal, E. A., & Day, A. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.3968 · Cited by 217 · see citing works
Nox enzymes as novel targets for drug development
Lambeth, J. D., Krause, K.-H., & Clark, R. A. (2008) · Seminars in Immunopathology · doi:10.1007/s00281-008-0123-6 · Cited by 212 · see citing works
Rauf, A., Khalil, A. A., Awadallah, S. M., Khan, S. A., Abu‐Izneid, T., Kamran, M., Hemeg, H. A., Mubarak, M. S., Khalid, A., & Wilairatana, P. (2023) · Food Science & Nutrition · doi:10.1002/fsn3.3784 · Cited by 201 · see citing works
Pharmacological characterization of the seven human NOX isoforms and their inhibitors
Augsburger, F., Филиппова, А., Rasti, D., Seredenina, T. S., Lam, M. A., Maghzal, G. J., Mahiout, Z., Jansen‐Dürr, P., Knaus, U. G., Doroshow, J. H., et al. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101272 · Cited by 192 · see citing works
NADPH Oxidases: From Molecular Mechanisms to Current Inhibitors
Cipriano, A., Viviano, M., Feoli, A., Milite, C., Sarno, G., Castellano, S., & Sbardella, G. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00770 · Cited by 190 · see citing works
Wind, S., Beuerlein, K., Armitage, M. E., Taye, A., Kumar, A. H. S., Janowitz, D., Neff, C., Shah, A. M., Wingler, K., & Schmidt, H. H. H. W. (2010) · Hypertension · doi:10.1161/hypertensionaha.109.149187 · Cited by 181 · see citing works
Self-citationPatten, D. A., Lafleur, V. N., Robitaille, G. A., Chan, D. A., Giaccia, A. J., & Richard, D. E. (2010) · Molecular Biology of the Cell · doi:10.1091/mbc.e10-01-0025 · Cited by 171 · see citing works
NADPH oxidase family proteins: signaling dynamics to disease management
Begum, R., Thota, S., Abdulkadir, A. S., Kaur, G., Bagam, P., & Batra, S. (2022) · Cellular and Molecular Immunology · doi:10.1038/s41423-022-00858-1 · Cited by 148 · see citing works
Neuroprotection After Stroke by Targeting NOX4 As a Source of Oxidative Stress
Radermacher, K. A., Wingler, K., Langhauser, F., Altenhöfer, S., Kleikers, P. W. M., Hermans, J. J. R., de Angelis, M. H., Kleinschnitz, C., & Schmidt, H. H. H. W. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.4797 · Cited by 147 · see citing works
Self-citationThe nox4 inhibitor gkt137831 attenuates hypoxia-induced pulmonary vascular cell proliferation
Green, D. E., Murphy, T. C., Kang, B.-Y., Kleinhenz, J. M., Szyndralewiez, C., Page, P., Sutliff, R. L., & Hart, C. M. (2012) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2011-0418oc · Cited by 146 · see citing works
NADPH Oxidase Inhibitors: New Antihypertensive Agents?
Williams, H. C., & Griendling, K. K. (2007) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e318063e820 · Cited by 146 · see citing works
Redox Control of Renal Function and Hypertension
Nistala, R., Whaley‐Connell, A. T., & Sowers, J. R. (2008) · Antioxidants and Redox Signaling · doi:10.1089/ars.2008.2034 · Cited by 146 · see citing works
NADPH oxidases: key modulators in aging and age-related cardiovascular diseases?
Sahoo, S., Meijles, D. N., & Pagano, P. J. (2016) · Clinical Science · doi:10.1042/cs20150087 · Cited by 146 · see citing works
Oxidative stress in chronic vascular disease: From prediction to prevention
Santilli, F., D’Ardes, D., & Davı̀, G. (2015) · Vascular Pharmacology · doi:10.1016/j.vph.2015.09.003 · Cited by 140 · see citing works
NADPH oxidases as therapeutic targets in ischemic stroke
Kahles, T., & Brandes, R. P. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1011-8 · Cited by 133 · see citing works
Targeting Oxidative Stress as a Therapeutic Approach for Idiopathic Pulmonary Fibrosis
Estornut, C., Milara, J., Bayarri, M. A., Belhadj, N., & Cortijo, J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.794997 · Cited by 135 · see citing works
The NADPH Oxidase Family and its Inhibitors
Kleniewska, P., Piechota-Polańczyk, A., Skibska, B., & Gorąca, A. (2012) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-012-0176-z · Cited by 129 · see citing works
Redox regulation of the actin cytoskeleton and its role in the vascular system
Xu, Q., Huff, L. P., Fujii, M., & Griendling, K. K. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.03.004 · Cited by 129 · see citing works
Src redox regulation: Again in the front line
Giannoni, E., Taddei, M. L., & Chiarugi, P. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.04.025 · Cited by 121 · see citing works
Kreisel, D., Sugimoto, S., Zhu, J., Nava, R. G., Li, W., Okazaki, M., YAMAMOTO, S., Ibrahim, M., Huang, H. J., Toth, K. A., et al. (2011) · Blood · doi:10.1182/blood-2011-04-347823 · Cited by 118 · see citing works
Oxidative Stress, Nox Isoforms and Complications of Diabetes—Potential Targets for Novel Therapies
Sedeek, M. H., Montezano, A. C. I., Hébert, R., Gray, S. P., Marco, E. D., Jha, J. C., Cooper, M. E., Jandeleit-Dahm, K. A. M., Schiffrin, E. L., Wilkinson‐Berka, J. L., et al. (2012) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-012-9387-2 · Cited by 116 · see citing works
Wang, L., Yu, T., Lee, H., O'Brien, D. K., Sesaki, H., & Yoon, Y. (2015) · Cardiovascular Research · doi:10.1093/cvr/cvv005 · Cited by 119 · see citing works
Nox1, 2, 4, 5: Counting out oxidative stress
Wingler, K., Hermans, J., Schiffers, P., Moens, A., Paul, M., & Schmidt, H. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01249.x · Cited by 113 · see citing works
Self-citationUpdates of reactive oxygen species in melanoma etiology and progression
Liu, F., Dellinger, R. W., & Meyskens, F. L. (2014) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2014.04.007 · Cited by 116 · see citing works
Biomechanical Strain Exacerbates Inflammation on a Progeria‐on‐a‐Chip Model
Ribas, J., Zhang, Y. S., Pitrez, P. R., Leijten, J., Miscuglio, M., Rouwkema, J., Dokmeci, M. R., Nissan, X., Ferreira, L., & Khademhosseini, A. (2017) · Small · doi:10.1002/smll.201603737 · Cited by 115 · see citing works
TRPM2 dependence of ROS-induced NLRP3 activation in Alzheimer's disease
Aminzadeh, M., Roghani, M., Sarfallah, A., & Riazi, G. H. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.10.024 · Cited by 109 · see citing works
Teixeira-Santos, L., Albino‐Teixeira, A., & Pinho, D. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105280 · Cited by 103 · see citing works
NADPH oxidases: redox regulation of cell homeostasis and disease
Kračun, D., Lopes, L. R., Cifuentes-Pagano, E., & Pagano, P. J. (2025) · Physiological Reviews · doi:10.1152/physrev.00034.2023 · Cited by 104 · see citing works
NADPH oxidases: Current aspects and tools
Schröder, K. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101512 · Cited by 105 · see citing works
Cerebral Small Vessel Disease: Targeting Oxidative Stress as a Novel Therapeutic Strategy?
Silva, T. M. D., & Miller, A. A. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00061 · Cited by 104 · see citing works
Efimova, O., Szankasi, P., & Kelley, T. W. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016013 · Cited by 100 · see citing works
DeVallance, E., Li, Y., Jurczak, M. J., Cifuentes-Pagano, E., & Pagano, P. J. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2018.7674 · Cited by 99 · see citing works
NADPH Oxidases as Regulators of Tumor Angiogenesis: Current and Emerging Concepts
Coso, S., Harrison, I., Harrison, C. B., Vinh, A., Sobey, C. G., Drummond, G. R., Williams, E. D., & Selemidis, S. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4489 · Cited by 99 · see citing works
Targeting Mitochondria and Reactive Oxygen Species-Driven Pathogenesis in Diabetic Nephropathy
Lindblom, R. S. J., Higgins, G. C., Coughlan, M. T., & de Haan, J. B. (2015) · The Review of Diabetic Studies · doi:10.1900/rds.2015.12.134 · Cited by 98 · see citing works
NOX2 As a Target for Drug Development: Indications, Possible Complications, and Progress
Diebold, B. A., Smith, S. M., Yang, L., & Lambeth, J. D. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.5862 · Cited by 96 · see citing works
Lange, S., Heger, J., Euler, G., Wartenberg, M., Piper, H. M., & Sauer, H. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn258 · Cited by 96 · see citing works
Self-citationThe role of NOX inhibitors in neurodegenerative diseases
Barua, S., Kim, J. Y., Yenari, M. A., & Lee, J. E. (2019) · IBRO Reports · doi:10.1016/j.ibror.2019.07.1721 · Cited by 91 · see citing works
NADPH oxidase inhibitors: a decade of discovery from Nox2ds to HTS
Cifuentes-Pagano, E., Csányi, G., & Pagano, P. J. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1009-2 · Cited by 92 · see citing works
ten Freyhaus, H., Dagnell, M., Leuchs, M., Vantler, M., Berghausen, E. M., Caglayan, E., Weißmann, N., Dahal, B. K., SCHERMULY, R. T., Östman, A., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200911-1663oc · Cited by 91 · see citing works
Self-citationNOXious signaling in pain processing
Kallenborn-Gerhardt, W., Schröder, K., Geißlinger, G., & Schmidtko, A. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.11.001 · Cited by 91 · see citing works
Apocynin-induced vasodilation involves Rho kinase inhibition but not NADPH oxidase inhibition
Schluter, T., Steinbach, A. C., Steffen, A., Rettig, R., & Grisk, O. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn185 · Cited by 90 · see citing works
The NADPH Oxidase Family and Its Inhibitors
Chocry, M., & Leloup, L. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7915 · Cited by 89 · see citing works
Bitar, M. S., & Al‐Mulla, F. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00047.2011 · Cited by 89 · see citing works
Pharmacology and Clinical Drug Candidates in Redox Medicine
Dao, V. T.-V., Casas, A. I., Maghzal, G. J., Seredenina, T., Kaludercic, N., Robledinos-Anton, N., Di Lisa, F., Stocker, R., Ghezzi, P., Jaquet, V., et al. (2015) · Antioxidants & Redox Signaling · doi:10.1089/ars.2015.6430 · Cited by 88 · see citing works
Reactive Oxygen Species: Not Omnipresent but Important in Many Locations
Herb, M., Gluschko, A., & Schramm, M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.716406 · Cited by 88 · see citing works
Bäumer, A. T., ten Freyhaus, H., Sauer, H., Wartenberg, M., Kappert, K., Schnabel, P., Konkol, C., Hescheler, J., Vantler, M., & Rosenkranz, S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704997200 · Cited by 87 · see citing works
Self-citationRedox Control of Vascular Smooth Muscle Migration
Martín, A. S., & Griendling, K. K. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2852 · Cited by 88 · see citing works
Reactive oxygen species and erectile dysfunction: possible role of NADPH oxidase
Jeremy, J. Y., Jones, R. A., Koupparis, A. J., Hotston, M. R., Persad, R. A., Angelini, G. D., & Shukla, N. (2006) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3901523 · Cited by 86 · see citing works
Are reactive oxygen species still the basis for diabetic complications?
Marco, E. D., Jha, J. C., Sharma, A., Wilkinson‐Berka, J. L., Jandeleit-Dahm, K. A. M., & de Haan, J. B. (2015) · Clinical Science · doi:10.1042/cs20150093 · Cited by 86 · see citing works
Linking RAGE and Nox in diabetic micro- and macrovascular complications
Koulis, C., Watson, A. M. D., Gray, S. P., & Jandeleit-Dahm, K. A. M. (2015) · Diabetes & Metabolism · doi:10.1016/j.diabet.2015.01.006 · Cited by 86 · see citing works
Reactive Oxygen Species in Vascular Formation and Development
Zhou, Y., Yan, H. M., Guo, M., Zhu, J., Xiao, Q., & Zhang, L. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/374963 · Cited by 85 · see citing works
NADPH Oxidases NOXs and DUOXs as Putative Targets for Cancer Therapy
Weyemi, U., Redon, C. E., Parekh, P. R., Dupuy, C., & Bonner, W. M. (2013) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520611313030013 · Cited by 85 · see citing works
The Quest for Selective Nox Inhibitors and Therapeutics: Challenges, Triumphs and Pitfalls
Cifuentes-Pagano, E., Meijles, D. N., & Pagano, P. J. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5620 · Cited by 84 · see citing works
Ashino, T., Yamamoto, M. P., Yoshida, T., & Numazawa, S. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.300614 · Cited by 84 · see citing works
Therapeutic strategies of diabetic nephropathy: recent progress and future perspectives
Lv, M., Chen, Z., Hu, G., & Li, Q. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.10.007 · Cited by 83 · see citing works
Chen, C., Puliafito, A., Cox, B. D., Primo, L., Fang, Y., Talia, S. D., & Poss, K. D. (2016) · Developmental Cell · doi:10.1016/j.devcel.2016.02.017 · Cited by 83 · see citing works
Oxidative Stress Orchestrates Cell Polarity to Promote Embryonic Wound Healing
Hunter, M. V., Willoughby, P. M., Bruce, A. E. E., & Fernández‐González, R. (2018) · Developmental Cell · doi:10.1016/j.devcel.2018.10.013 · Cited by 81 · see citing works
Bao, X.-M., Wu, C., & Lu, G.-P. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.11.032 · Cited by 81 · see citing works
Microvascular NADPH oxidase in health and disease
Li, Y., & Pagano, P. J. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.02.049 · Cited by 79 · see citing works
How T cells trigger the dissociation of the endothelial receptor phosphatase VE-PTP from VE-cadherin
Vockel, M., & Vestweber, D. (2013) · Blood · doi:10.1182/blood-2013-04-499228 · Cited by 79 · see citing works
Godfrey, R., Arora, D., Bauer, R., Stopp, S., Müller, J. P., Heinrich, T., Böhmer, S., Dagnell, M., Schnetzke, U., Scholl, S., et al. (2012) · Blood · doi:10.1182/blood-2011-02-336446 · Cited by 78 · see citing works
Isoform-selective NADPH oxidase inhibitor panel for pharmacological target validation
Dao, V. T.-V., Elbatreek, M. H., Altenhöfer, S., Casas, A. I., Pachado, M. P., Neullens, C. T., Knaus, U. G., & Schmidt, H. H. H. W. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.12.038 · Cited by 77 · see citing works
Sun, Q.-A., Hess, D. T., Wang, B., Miyagi, M., & Stamler, J. S. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.02.046 · Cited by 76 · see citing works
Inhibiting the Activity of NADPH Oxidase in Cancer
Konaté, M. M., Antony, S., & Doroshow, J. H. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8046 · Cited by 77 · see citing works
Redox‐based therapeutics in neurodegenerative disease
McBean, G. J., López, M. G., & Wallner, F. K. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13551 · Cited by 75 · see citing works
Octavia, Y., Rocca, H. B., & Moens, A. L. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.10.482 · Cited by 75 · see citing works
Frasier, C. R., Moukdar, F., Patel, H. D., Sloan, R. C., Stewart, L. M., Alleman, R. J., Favor, J. D. L., & Brown, D. A. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt009 · Cited by 75 · see citing works
Targeting oxidative stress and anti-oxidant defence in diabetic kidney disease
Østergaard, J. A., Cooper, M. E., & Jandeleit-Dahm, K. A. M. (2020) · Journal of Nephrology · doi:10.1007/s40620-020-00749-6 · Cited by 75 · see citing works
NADPH oxidase in stroke and cerebrovascular disease
Tang, X. N., Cairns, B., Kim, J. Y., & Yenari, M. A. (2012) · Neurological Research · doi:10.1179/1743132812y.0000000021 · Cited by 73 · see citing works
Gatto, G. J. J., Ao, Z., Kearse, M. G., Zhou, M., Morales, C. R., Daniels, E., Bradley, B. T., Goserud, M. T., Goodman, K. B., Douglas, S. A., et al. (2011) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2011.636360 · Cited by 74 · see citing works
Margaritelis, N. V., Cobley, J. N., Paschalis, V., Veskoukis, A. S., Theodorou, A. A., Kyparos, A., & Nikolaidis, M. G. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.12.011 · Cited by 71 · see citing works
Touyz, R. M., & Montezano, A. C. I. (2012) · Circulation Research · doi:10.1161/circresaha.112.269068 · Cited by 72 · see citing works
Munnamalai, V., Weaver, C. J., Weisheit, C. E., Venkatraman, P., Agim, Z. S., Quinn, M. T., & Suter, D. M. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12734 · Cited by 70 · see citing works
NADPH oxidase inhibitors: a patent review
Kim, J., Neupane, G. P., Lee, E. S., Jeong, B., Park, B. C., & Thapa, P. (2011) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2011.584870 · Cited by 69 · see citing works
Redox Circuitries Driving Src Regulation
Giannoni, E., & Chiarugi, P. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5525 · Cited by 69 · see citing works
- Authors
- TENFREYHAUS, H., HUNTGEBURTH, M., WINGLER, K., SCHNITKER, J., BAUMER, A., VANTLER, M., BEKHITE, M., WARTENBERG, M., SAUER, H., & ROSENKRANZ, S.
- Affiliations
- University of Cologne (DE)
- Vasopharm (Germany) (DE)
- Justus-Liebig-Universität Gießen (DE)
- Corresponding author
- ROSENKRANZ, S
- Venue
- Cardiovascular Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-07-15
- Volume
- 71
- Issue
- 2
- Pages
- 331-341
- ISSN
- 0008-6363 (ISSN-L)
- OpenAlex
- W2136386024
- Cited by
- 259
- References
- 46
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 4 · 2023: 8 · 2022: 7 · 2021: 13 · 2020: 15 · 2019: 15 · 2018: 13 · 2017: 14 · 2016: 9 · 2015: 19 · 2014: 22 · 2013: 24 · 2012: 22
- FWCI
- 7.51
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cardiovascular Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology › Nitric Oxide and Endothelin Effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Life Sciences › Immunology and Microbiology › Immunology › Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Keywords
- VAS2870, platelet-derived growth factor, vascular smooth muscle cells, reactive oxygen species, cell proliferation, Src kinase, Akt, ERK, PDGF signaling, cell migration, DNA synthesis, cardiovascular disease, redox signaling, chemiluminescence, BrdU incorporation, immunofluorescence
- MeSH terms
- Becaplermin, Animals, Aorta, Thoracic, Benzoxazoles, Cell Survival, Cells, Cultured, Chemotaxis, DNA, Enzyme Inhibitors, Muscle, Smooth, Vascular, Platelet-Derived Growth Factor, Rats, Inbred WKY, Triazoles, Blotting, Western, Reactive Oxygen Species, src-Family Kinases, NADPH Oxidases, Proto-Oncogene Proteins c-sis, Myocytes, Smooth Muscle, Immunoprecipitation, Cell Proliferation, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review